Projects research

INFO & CONTACTS: +39 02 2390 1

Search

Search

Identification of quantitative factors and support tools to reduce the risk of adverse events after oncological treatments

Funding Entity: AIRC MFAG 27480 (Location Matters) Direzione Scientifica, Fondazione IRCCS Istituto Nazionale dei Tumori

Principal Investigator: Dr. De Santis Maria Carmen - Co Principal Investigator: Dr. Vallerio Paola

Start date: 01/01/2023

Main Facility: Data Science
Dissecting immunological effects of neoadjuvant therapies in primary high-risk soft tissue sarcomas

Funding Entity: AIRC Individual Grant - Next Gen Clinician Scientist 2023

Principal Investigator: Dott. Pasquali Sandro

Start date: 01/01/2023 - End date: 31/12/2027

Main Facility: Molecular Pharmacology
ZEB1 defines suppressive neutrophils and neutrophil extracellular traps in non-small cell lung cancer.

Funding Entity: Bando per la Ricerca Istituzionale

Principal Investigator: Dr. Brambilla Marta - Co Principal Investigator: Dr. Proto Claudia

Start date: 01/01/2023 - End date: 31/12/2026

Main Facility:
TYME: TYmic Malignancies nEtwork per l’integrazione di dati real world e per la caratterizzazione biologica dei tumori epiteliali del timo

Funding Entity: Bando per la Ricerca Istituzionale (BRI)

Principal Investigator: Dr. Proto Claudia

Start date: 01/01/2023 - End date: 31/12/2033

Main Facility:
Discovering of Biomarkers for Immune Checkpoint Blockade in Pleural Mesothelioma.

Funding Entity: Bando per la Ricerca Istituzionale

Principal Investigator: Dott. Occhipinti Mario - Co Principal Investigator: Dott. Lorenzini Daniele

Start date: 01/01/2023 - End date: 31/12/2026

Main Facility:
YOUGOODY: Good and Healthy Research. Lifestyle and dietary habits at the heart of research on chronic-degenerative diseases

Funding Entity: Fondazione IRCCS Istituto Nazionale dei Tumori

Principal Investigator: Dr. Sieri Sabina

Start date: 01/01/2023 - End date: 31/12/2026

Main Facility: Epidemiology and Prevention
Intelligent Ecosystem to improve the governance, the sharing and the re-use of health Data for Rare Cancers - IDEA4RC

Funding Entity: European Health and Digital Executive Agency (HADEA)

Principal Investigator: Dr. Trama Annalisa

Start date: 01/09/2022 - End date: 31/08/2026

Main Facility: Evaluative Epidemiology
I3LUNG - Integrative science, Intelligent data platform for Individualized Lung cancer care with Immunotherapy

Funding Entity: Programma Horizon Europe

Principal Investigator: Dr. Prelaj Arsela

Start date: 01/06/2022 - End date: 31/05/2027

Main Facility: Oncologia Medica 1
SENESCENCE IN THYROID CANCER PROGRESSION AND THERAPY RESISTANCE: PRECLINICAL STUDIES AND THERAPEUTIC IMPLICATIONS

Funding Entity: AIRC

Principal Investigator: Dr. Greco Angela

Start date: 01/01/2022 - End date: 30/03/2027

Main Facility: Integrated Biology of Rare Tumors
PARP INHIBITORS IN FIRST LINE OVARIAN CANCER TREATMENT: PREDICTION OF RESPONSE AND RESISTANCE

Funding Entity: Ministero della Salute

Principal Investigator: Dr. Mezzanzanica Delia

Start date: 01/01/2022 - End date: 31/12/2025

Main Facility: Pathological Anatomy 1
Harnessing Altered Choline Metabolism To Hinder Chemoresistance And Aggressiveness Of Ovarian Cancer

Funding Entity: AIRC

Principal Investigator: Dr. PhD Bagnoli Marina

Start date: 01/01/2022 - End date: 31/12/2026

Main Facility: Gynecologic Surgical Oncology
DISSECT THE EFFECTS OF COPZ1 TARGETING: A PROMISING STRATEGY FOR DIFFERENT SOLID TUMORS

Funding Entity: Ministero della Salute

Principal Investigator: Dr. Greco Angela

Start date: 15/06/2021 - End date: 14/06/2025

Main Facility: Integrated Biology of Rare Tumors
pRedicting cardiOvascular diSeAses iN adolescent and young breast caNcer pAtients (ROSANNA)

Funding Entity: Fondazione AIRC per la Ricerca sul Cancro

Principal Investigator: Dr. Trama Annalisa

Start date: 02/01/2021 - End date: 01/01/2026

Main Facility: Evaluative Epidemiology
Organ microbiome: identification of the endogenous (commensal) 'non-human' component with translational, diagnostic, prognostic, and therapeutic potential

Funding Entity: Ministero della Salute- Ricerca Corrente

Principal Investigator: Dr. Sozzi Gabriella

Start date: 01/01/2021 - End date: 31/12/2025

Main Facility: Epigenomics and Biomarkers of Solid Tumors
Understanding why childhood cancer survival varies between countries (“BENCHISTA” - International Benchmarking of Childhood cancer Survival by Toronto Stage at diagnosis)

Funding Entity: Children with cancer UK, Fondazione AIRC per la Ricerca sul Cancro (Italian association on cancer research)

Start date: 01/01/2021 - End date: 01/01/2026

Main Facility: Evaluative Epidemiology
Circulating microRNAs to choose the IO strategy in PD-L1 ≥50% NSCLC patients: the Ark clinical trial

Funding Entity: Bando per la Ricerca Istituzionale

Principal Investigator: Dr. Proto Claudia - Co Principal Investigator: Dott. Boeri Mattia

Start date: 01/01/2021 - End date: 31/12/2025

Main Facility:
Big Data Models and Intelligent tools for Quality of Life monitoring and participatory empowerment of head and neck cancer survivors (BD4QoL)

Funding Entity: H2020, Grant Agreement 875192

Principal Investigator: Professoressa Associata Licitra Lisa Francesca Linda - Co Principal Investigator: Dott. Cavalieri Stefano

Start date: 01/01/2020 - End date: 31/12/2025

Main Facility: Oncologia Medica 3 - Tumori testa-collo
Cancer Cell-Intrinsic PD-1 and immune-microenvironment boost tumor growth upon immune-checkpoint inhibitors in NSCLC

Funding Entity: MFAG AIRC

Principal Investigator: Dr. Lo Russo Giuseppe

Start date: 01/01/2020 - End date: 31/12/2025

Main Facility: Oncologia Medica 1 - Unità Oncologia Medica Melanomi
MRI Imaging for Active Surveillance in Prostate Cancer

Funding Entity: Direzione Scientifica, Fondazione IRCCS Istituto Nazionale dei Tumori

Start date: 01/01/2019

Main Facility: Data Science
Toolkit for Radiotherapy Data Quality Assurance and Dosimetric Metrics

Funding Entity: Direzione Scientifica, Fondazione IRCCS Istituto Nazionale dei Tumori | ERA-Permed European Partnership for personalised medicine [progetti RADprecise, PerPlanRT]

Start date: 01/01/2019

Main Facility: Data Science

Projects research

Subscribe to the newsletter